IL120101A0 - Urokinase receptor ligands - Google Patents

Urokinase receptor ligands

Info

Publication number
IL120101A0
IL120101A0 IL12010196A IL12010196A IL120101A0 IL 120101 A0 IL120101 A0 IL 120101A0 IL 12010196 A IL12010196 A IL 12010196A IL 12010196 A IL12010196 A IL 12010196A IL 120101 A0 IL120101 A0 IL 120101A0
Authority
IL
Israel
Prior art keywords
lower alkyl
halo
aryl
alkyl
cycloalkyl
Prior art date
Application number
IL12010196A
Other languages
English (en)
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of IL120101A0 publication Critical patent/IL120101A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL12010196A 1995-06-07 1996-06-06 Urokinase receptor ligands IL120101A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/485,021 US5747458A (en) 1995-06-07 1995-06-07 Urokinase receptor ligands
PCT/US1996/009648 WO1996040747A1 (en) 1995-06-07 1996-06-06 Urokinase receptor ligands

Publications (1)

Publication Number Publication Date
IL120101A0 true IL120101A0 (en) 1997-04-15

Family

ID=23926620

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12010196A IL120101A0 (en) 1995-06-07 1996-06-06 Urokinase receptor ligands

Country Status (14)

Country Link
US (2) US5747458A (fi)
EP (1) EP0777680B1 (fi)
JP (1) JPH10503784A (fi)
AT (1) ATE214711T1 (fi)
AU (1) AU6164096A (fi)
BR (1) BR9606429A (fi)
CA (1) CA2196334A1 (fi)
DE (1) DE69619940T2 (fi)
FI (1) FI970446A7 (fi)
HU (1) HUP9702220A3 (fi)
IL (1) IL120101A0 (fi)
MX (1) MX9700888A (fi)
NO (1) NO970513L (fi)
WO (1) WO1996040747A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519120A (en) * 1989-04-07 1996-05-21 Cancerforskningsfondet Af 1989 Urokinase-type plasminogen activator receptor antibodies
ID24525A (id) * 1997-07-31 2000-07-20 Hoffmann La Roche Turunan-turunan hidroksikumaranon tersubstitusi-0 sebagai zat anti tumor dan zat antimetastatik
WO1999055688A1 (en) * 1998-04-27 1999-11-04 Warner-Lambert Company Substituted diarylalkyl amides as calcium channel antagonists
US6228985B1 (en) 1998-05-21 2001-05-08 Schering Corporation Derivatives of aminobenzoic and aminobiphenylcarboxylic acids useful as anti-cancer agents
ES2169690B1 (es) * 2000-10-06 2004-03-16 Diverdrugs Sl Trimeros de n-alquilglicina capaces de proteger a neuronas contra agresiones excitotoxicas, y composiciones que los contienen.
ES2169691B1 (es) * 2000-10-11 2004-03-16 Diverdrugs Sl Trimeros de n-alquilglicina capaces de bloquear la respuesta a sustancias quimicas, estimulos termicos o mediadores de la inflamacion de receptores neuronales, y composiciones que los contienen.
CA2522203A1 (en) * 2003-04-15 2004-10-28 Gema Tarrason Identification of n-alkylglycine trimers for induction of apoptosis
CN103270022B (zh) 2010-08-31 2015-08-19 巴勃罗·比咯斯拉达 神经营养蛋白受体激动剂及其作为药物的应用
EP2647622B1 (en) * 2010-12-03 2017-04-19 Fujitsu Limited Kinesin spindle protein inhibitors and application thereof
IT202100023357A1 (it) 2021-09-09 2023-03-09 Cheirontech S R L Peptidi con attività anti-angiogenica

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247080A (en) * 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
WO1986000991A1 (en) * 1984-07-24 1986-02-13 Commonwealth Serum Laboratories Commission Method for determining mimotopes
NZ215865A (en) * 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
IE66205B1 (en) * 1990-06-14 1995-12-13 Paul A Bartlett Polypeptide analogs
PL308204A1 (en) * 1992-09-24 1995-07-24 Chiron Corp Synthesis of n-substituted oligomers
US5536853A (en) * 1994-04-11 1996-07-16 Chiron Corporation Opiate receptor ligands
ZA953361B (en) * 1994-04-26 1996-01-12 Selectide Corp Factor Xa inhibitors

Also Published As

Publication number Publication date
DE69619940T2 (de) 2002-12-19
WO1996040747A1 (en) 1996-12-19
BR9606429A (pt) 1997-09-02
HUP9702220A2 (hu) 1998-05-28
EP0777680B1 (en) 2002-03-20
FI970446L (fi) 1997-03-26
JPH10503784A (ja) 1998-04-07
NO970513D0 (no) 1997-02-05
CA2196334A1 (en) 1996-12-19
EP0777680A1 (en) 1997-06-11
FI970446A0 (fi) 1997-02-03
MX9700888A (es) 1997-04-30
AU6164096A (en) 1996-12-30
NO970513L (no) 1997-02-05
HUP9702220A3 (en) 1998-06-29
DE69619940D1 (de) 2002-04-25
US5747458A (en) 1998-05-05
US6121240A (en) 2000-09-19
FI970446A7 (fi) 1997-03-26
ATE214711T1 (de) 2002-04-15

Similar Documents

Publication Publication Date Title
HUT74367A (en) Fungicidal alpha-aryl-substituted cyclic amide derivatives, fungicid compositions containing these as active ingredients and using thereof
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
ATE220677T1 (de) Pyrazolotriazine mit interleukin-1 und tumor necrosis faktor inhibitor wirkung
EP0669324A4 (en) CHINAZOLIN DERIVATIVES.
CA2116967A1 (en) Antidepressants
NZ315469A (en) Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
CA2216129A1 (en) Lactam-containing hydroxamic acids
ATE237333T1 (de) Pharmazeutische mischungen, enthaltend sulphamatderivate als steroidsulfatasehemmende verbindungen
DE69420564D1 (de) Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)-homoserinlacton
NZ311647A (en) Rapamycin derivatives
AU2002231122A1 (en) Methods of treating anxiety disorders
EP0938317A4 (en) COMPOSITIONS AND METHODS FOR REDUCING RESPIRATORY DEPRESSION
EP0614661A3 (en) Benzylidene and cinnamylidene malononitrile derivatives to inhibit proliferative processes in mammalian cells.
CA2149496A1 (en) 11,21-bisphenyl-19-norpregnane derivatives
AU6164096A (en) Urokinase receptor ligands
NZ334954A (en) Substituted heterocycles as anti-tumor agents
GEP20022653B (en) Processes and Intermediates for Preparing Anti-Cancer Compounds
ATE224872T1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
UA27057C2 (uk) Засіб для іhгібуваhhя фіброзу матки
ES2093091T3 (es) Derivado de glutation.
SE9704770D0 (sv) New use
JPS57126461A (en) Novel guanidino compound and its preparation
AP2000002009A0 (en) Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity.
DE60000405D1 (de) 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression
ES2103204A1 (es) Derivados quirales de hidroxifenilglicina y su empleo en la sintesis de principios activos farmaceuticos.